Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. 

Biotechnology

Cara Therapeutics

Cara Therapeutics' headquarters in Stamford, CT, United States

Christopher Posner

Frédérique Menzaghi

Scott Terrillion

Jo Goncalves

Andrew Albright

Ryan Maynard

Eric Vandal

Jeffrey L. Ives

Lisa von Moltke

Martin Vogelbaum

Helen M. Boudreau

The Research and Development team at Cara Therapeutics is dedicated to innovating and advancing new therapeutic candidates aimed at treating pruritus through the selective targeting of peripheral kappa opioid receptors. This multidisciplinary team, comprised of experts in scientific research, clinical strategy, and operational management, collaborates to optimize drug development processes, from initial discovery through clinical trials, ensuring alignment with regulatory standards and market needs.

Research and Development

The Clinical Operations team at Cara Therapeutics is responsible for managing and executing clinical trials to evaluate the safety and efficacy of new therapeutics targeting peripheral kappa opioid receptors. This team collaborates closely with cross-functional partners to ensure that studies are conducted in compliance with regulatory standards, timelines, and budgets, while also overseeing data management and analysis to support the advancement of innovative treatments for pruritus.

Clinical Operations

The Leadership Team at Cara Therapeutics plays a crucial role in guiding the company's strategic direction, overseeing research and development, and ensuring regulatory compliance. They collaborate to drive the commercialization of innovative therapies targeting pruritus, while managing investor relations, financial operations, and overall corporate governance to achieve the company's mission of improving patient outcomes.

Leadership Team

The Regulatory and Quality Assurance Team at Cara Therapeutics ensures that all products meet regulatory standards and comply with industry guidelines throughout the development process. This team manages clinical supply logistics, drug safety data, and procurement, while overseeing quality assurance practices to facilitate successful regulatory submissions and maintain product integrity. Their efforts are crucial for advancing the company's innovative therapies for pruritus.

Regulatory and Quality Assurance Team

The Finance and Accounting team at Cara Therapeutics is responsible for managing the company's financial planning, reporting, and accounting operations. This team ensures accurate financial statements, oversees budgeting processes, and implements financial strategies that support the company's growth and regulatory compliance in the biopharmaceutical sector. Additionally, they provide insights and analyses to inform strategic decision-making, enabling effective resource allocation for research and development initiatives.

Cara Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Leadership Team

Regulatory and Quality Assurance Team

Finance and Accounting

Offices

Cara Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Leadership Team

Regulatory and Quality Assurance Team

Finance and Accounting

Offices

Related companies